Activity value 79International Buyer&Supplier,Last transaction date:
2026-02-23
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for shanghai acebright pharmaceuticals group co.ltd. from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 7 transactions, with a transaction quantity of 16 and a transaction weight of 0.
Product description
COMPOSTOS HETEROCíCLICOS EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE OXIGéNIO|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS
Expand
Trade date
2025/11/01
B/L No.
——
Suppliers
shanghai acebright pharmaceuticals group co.ltd.
Buyers
libbs farmaceutica ltd.
Product description
COMPOSTOS HETEROCíCLICOS EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE OXIGéNIO|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS
Expand
Trade date
2025/11/01
B/L No.
——
Suppliers
shanghai acebright pharmaceuticals group co.ltd.
Buyers
uniao quimica farmaceutica nacional
Product description
HORMONAS, PROSTAGLANDINAS, TROMBOXANOS E LEUCOTRIENOS, NATURAIS OU REPRODUZIDOS POR SíNTESE; SEUS DERIVADOS E ANáLOGOS ESTRUTURAIS, INCLUINDO OS POLIPéPTIDOS DE CADEIA MODIFICADA, UTILIZADOS PRINCIPALMENTE COMO HORMONAS|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS FARMACêUTICOS, PRODUTOS QUíMICOS MEDICINAIS E BOTâNICOS|HORMONIOS NATURAIS, REPROD.POR SINTESE E SEUS DERIVADOS
Expand
Trade date
2025/11/01
B/L No.
——
Suppliers
shanghai acebright pharmaceuticals group co.ltd.
Buyers
libbs farmaceutica ltd.
Product description
COMPOSTOS HETEROCíCLICOS EXCLUSIVAMENTE DE HETERO-áTOMO(S) DE OXIGéNIO|INSUMOS INDUSTRIAIS ELABORADOS|PRODUTOS MANUFATURADOS|FABRICAçãO DE PRODUTOS QUíMICOS BáSICOS|COMPOSTOS HETEROCICLICOS, SEUS SAIS E SULFONAMIDAS
Expand
Trade date
2025/11/01
B/L No.
——
Suppliers
shanghai acebright pharmaceuticals group co.ltd.
Buyers
aet laboratories ltd.
Product description
NERATINIB MALEATE B N DA3461 240901 6 FREE SAMPLE FREE OF CHARGE NO COMMERCIAL VALUE NERATINIB MALEATE B N DA3461 240901 6 FREE SAMPLE FRE
Expand
shanghai acebright pharmaceuticals group co.ltd. is International Buyer&Supplier,
and primarily engages in the import and export business of products such as regorafenib,working standard,ice.
According to the 52wmb.com global trade database, as of 2026-02-23, the company has completed 302 international trades,
with its main trading regions covering argentina,india,paraguay etc.
The core products include HS29333929,HS29335990,HS29334900 etc,
often transported via cnpvg,port beijing, port shanghai etc,
and its main trading partners are imports exp expo monte verde ltd.,aet laboratories ltd.,laboratorios richmond sacif.
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on shanghai acebright pharmaceuticals group co.ltd. is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.